Content Area
Menu
We are a globally active clinical research institute and academic study group specializing in investigator-initiated and industry–academia collaborative trials in medical oncology and hematology. Our mission is to advance science-driven cancer research, accelerate the development of innovative therapies, and address key clinical questions that matter to patients and physicians alike.
Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients.
Our collaborative models offer academic and biotech partners clear advantages
Our team of physicians, who have years of expertise and current knowledge in medical care, are specialized in the fields of hematology, oncology, surgical oncology, palliative medicine, supportive therapy, and human genetics. Our founders are oncologists, and this expertise is a hallmark of IKF.
With well-established networks of almost hundreds of medical institutions, the best experts in their respective fields for every disease type, and the largest academic study groups in Germany and Europe, IKF has a powerful network that sets us apart.
IKF provides well-established access to routine clinical oncology environments through long-term collaborations with university hospitals, other large hospitals, and private oncology practitioners.
Institute of Clinical Cancer Research IKF at Northwest Hospital
We are a globally acting clinical research institution specializing in investigator-initiated and industry-academia collaborative clinical cancer research.
Founded by oncologists driven by a shared vision to make a global impact, our mission is to advance science-driven cancer research through collaboration between industry and academia.
By leveraging the strengths and expertise of both sectors we strive to conduct transformative research and provide answers to crucial clinical questions.
Excellence in Research
Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients. As we are not a pharmaceutical company, our real “product” is the gain of scientific knowledge, which we achieve through clinical trials with our partners that focus on patient-relevant endpoints such as survival and quality of life.”
Sponsored by our institution and conducted on an international scale, our investigator-initiated trials result from collaborative efforts between our internal experts and external partners, including esteemed physicians and oncologists from various university hospitals.
Translational Research and IKF BioDataBank
We recognize the vital role of translational research in our study designs. We are dedicated to advancing our understanding of cancer pathogenesis and development, and to achieve this, we integrate translational elements into our research.
We aim at improving personalized cancer therapy with our academic partners by establishing large networks and registries for molecular profiling. Our interactive PLATON Network (Platform for Analyzing Targetable Mutations) brings together comprehensive molecular profiling, extensive clinical data of cancer patients, QoL, education, and clinical trial information to advance cancer research and treatment.
In addition to clinical trials, we conduct real-world studies in diverse healthcare settings. These studies provide valuable insights into the practical application of treatments, their effectiveness in routine care, and patient outcomes in real-world scenarios. By conducting research in real-life settings, we aim to bridge the gap between controlled clinical environments and the complexities of everyday clinical practice.
Excellence in Research
Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients. As we are not a pharmaceutical company, our real “product” is the gain of scientific knowledge, which we achieve through clinical trials with our partners that focus on patient-relevant endpoints such as survival and quality of life.”
Sponsored by our institution and conducted on an international scale, our investigator-initiated trials result from collaborative efforts between our internal experts and external partners, including esteemed physicians and oncologists from various university hospitals.
Translational Research and IKF BioDataBank
We recognize the vital role of translational research in our study designs. We are dedicated to advancing our understanding of cancer pathogenesis and development, and to achieve this, we integrate translational elements into our research.
We aim at improving personalized cancer therapy with our academic partners by establishing large networks and registries for molecular profiling. Our interactive PLATON Network (Platform for Analyzing Targetable Mutations) brings together comprehensive molecular profiling, extensive clinical data of cancer patients, QoL, education, and clinical trial information to advance cancer research and treatment.
In addition to clinical trials, we conduct real-world studies in diverse healthcare settings. These studies provide valuable insights into the practical application of treatments, their effectiveness in routine care, and patient outcomes in real-world scenarios. By conducting research in real-life settings, we aim to bridge the gap between controlled clinical environments and the complexities of everyday clinical practice.
Excellence in Research
Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients. As we are not a pharmaceutical company, our real “product” is the gain of scientific knowledge, which we achieve through clinical trials with our partners that focus on patient-relevant endpoints such as survival and quality of life.”
Sponsored by our institution and conducted on an international scale, our investigator-initiated trials result from collaborative efforts between our internal experts and external partners, including esteemed physicians and oncologists from various university hospitals.
Translational Research and IKF BioDataBank
We recognize the vital role of translational research in our study designs. We are dedicated to advancing our understanding of cancer pathogenesis and development, and to achieve this, we integrate translational elements into our research.
We aim at improving personalized cancer therapy with our academic partners by establishing large networks and registries for molecular profiling. Our interactive PLATON Network (Platform for Analyzing Targetable Mutations) brings together comprehensive molecular profiling, extensive clinical data of cancer patients, QoL, education, and clinical trial information to advance cancer research and treatment.
In addition to clinical trials, we conduct real-world studies in diverse healthcare settings. These studies provide valuable insights into the practical application of treatments, their effectiveness in routine care, and patient outcomes in real-world scenarios. By conducting research in real-life settings, we aim to bridge the gap between controlled clinical environments and the complexities of everyday clinical practice.